.png){kind=icon}
返回
Identity-Based Encryption with Outsourced Revocation in Cloud Computing
.png){kind=icon}
OA
AI
DOI：10.1109/TC.2013.208.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Identity-Based Encryption (IBE) which simplifies the public key and certificate management at Public Key Infrastructure (PKI) is an important alternative to public key encryption. However, one of the main efficiency drawbacks of IBE is the overhead computation at Private Key Generator (PKG) during user revocation. Efficient revocation has been well studied in traditional PKI setting, but the cumbersome management of certificates is precisely the burden that IBE strives to alleviate. In this paper, aiming at tackling the critical issue of identity revocation, we introduce outsourcing computation into IBE for the first time and propose a revocable IBE scheme in the server-aided setting. Our scheme offloads most of the key generation related operations during key-issuing and key-update processes to a Key Update Cloud Service Provider, leaving only a constant number of simple operations for PKG and users to perform locally. This goal is achieved by utilizing a novel collusion-resistant technique: we employ a hybrid private key for each user, in which an AND gate is involved to connect and bound the identity component and the time component. Furthermore, we propose another construction which is provable secure under the recently formulized Refereed Delegation of Computation model. Finally, we provide extensive experimental results to demonstrate the efficiency of our proposed construction.
Keyword:
Identity-based encryption (IBE)
revocation
outsourcing
cloud computing
期刊
IF:
3.8
论文数:
5.3K
被引数:
9.8K
机构
引用论文
Structure of pyridinium catena-μ-chloro-chloro(3,4,5,6-tetrachloropyrocatecholato)antimonate(III)
PREAI
分享收藏
分享收藏分享收藏Ctdp1 deficiency leads to early embryonic lethality in mice and defects in cell cycle progression in MEFs.png)
Biology OpenOAAI
Biology OpenIF0
OAAI分享收藏Gefitinib-Induced Hepatotoxicity in Patients Treated for Non-Small Cell Lung CancerOnkologie
OnkologieIF0
PREAI
分享收藏
查看更多内容